A purpose-built clinical-trial smartphone is more than a consumer device with an app installed.
It is designed around the operational requirements of decentralised and hybrid studies, including device consistency, controlled configuration, connectivity, replacement planning, long-term support and patient-facing usability.
STK Helix is a purpose-built 5G AI-native smartphone for clinical research. It is designed to support workflows such as eCOA, ePRO, remote participation, multilingual engagement, biometric identity processes and provisioned-device programmes.
The distinction matters. Consumer smartphones are built for fast retail cycles and broad consumer use. Clinical-trial programmes may require a consistent device environment across multiple countries, participant groups and study phases.
What study teams need to consider
That means study teams need to consider:
- OS and application control
- Battery performance and device lifecycle
- Global connectivity and certification
- Provisioning, logistics and replacement
- Accessibility and participant burden
- Consistent data-capture environments
Helix provides the hardware foundation. STK Cortex™ is the AI capability layer being developed to support areas such as on-device processing, reminders, multilingual engagement, voice and image workflows.
Together with STK Nexus™ connectivity and STK’s manufacturing experience since 1993, Helix is intended to support reliable, scalable clinical-trial device infrastructure.
Clinical-trial devices should be treated as infrastructure, not accessories.